651. Multistate Investigation of an Outbreak Associated with a Contaminated Steroid
Session: Symposium: Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters
Friday, October 4, 2013: 10:30 AM
Room: The Moscone Center: 104 (Gateway Ballroom)
Marion a. Kainer, MBBS, MPH, Tennessee Department of Health, Nashville, TN

Dr. Kainer obtained her medical degree and masters of public health in Melbourne, Australia. She is an adult infectious diseases physician and healthcare epidemiologist. She was an Epidemic Intelligence Service officer at the US Centers for Disease Control and Prevention (CDC), in the Division of Healthcare Quality Promotion. Dr. Kainer joined the Tennessee Department of Health in 2003 where she is the director of the Healthcare Associated Infections and Antimicrobial Resistance Program. She is the chair of the healthcare associated infections [HAI] subcommittee of the Council of State and Territorial Epidemiologists [CSTE]. She co-chairs the CSTE HAI data standards committee and co-chairs the antimicrobial resistance reporting working group. Dr. Kainer serves as the CSTE liaison to the Healthcare Infection Control Practices Advisory Committee [HICPAC], the National Healthcare Safety Network (NHSN) steering committee, the NHSN change control board and the Emerging Infections Program (EIP) Active Bacterial Core (ABC)Surveillance Steering Committee. She serves on the public policy and governmental affairs committee of the Society for Healthcare Epidemiology of America (SHEA). Dr. Kainer has led the recent fungal meningitis outbreak investigation at the Tennessee Department of Health and was named Tennessean of the Year by the Nashville based Tennessean newspaper. In 2013, she was honored by the White House as a Champion of Change for Public Health and Prevention.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.